VSee Health, Inc. (NASDAQ: VSEE) AI-Powered Stock Analysis
See how VSee Health, Inc. scores across key metrics like financial growth, valuation, and market position on the NASDAQ, using AI-driven evaluation.
VSEE●NASDAQ
HealthcareMedical - Healthcare Information Services
$0.08
$0.003(3.07%)
U.S. Market opens in 63h 26m
VSee Health, Inc. (NASDAQ: VSEE) AI-Powered Stock Analysis
See how VSee Health, Inc. scores across key metrics like financial growth, valuation, and market position on the NASDAQ, using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continuously improving this model to increase accuracy and performance.Read our Full DisclaimerVSee Health, Inc. (NASDAQ: VSEE) Stock Overall Grade
VSee Health, Inc.'s grade for its NASDAQ listing, based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to VSee Health, Inc.'s overall NASDAQ stock rating.
Forecast
CScore
49/100Financial Growth
CScore
40/100Fundamental Growth
CScore
40/100Key Ratios
C+Score
55/100Sector Comparison
AScore
80/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
97/100Analyst Consensus
C+Score
50/100VSee Health, Inc. (NASDAQ: VSEE) AI-Powered Stock Analysis
On the NASDAQ, VSEE demonstrates Normal performance with an overall Forecast Score of 49/100 (C), reflecting weak confidence in its potential. Financial Growth (40/100, C) and Fundamental Growth (40/100, C) highlight its stability, while Key Ratios (55/100, C+) and Sector Comparison (80/100, A) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (97/100, A+), the NASDAQ-listed stock shows competitive strength. Analyst Consensus (50/100, C+) suggests High divergence in outlook.(NASDAQ: VSEE) Component Analysis Explained
Understand the key factors behind each VSee Health, Inc. (NASDAQ: VSEE) stock grade, including financials, comparisons, and forecasts.